Product
Erythropoietin
Aliases
EPO, Eprex
11 clinical trials
23 indications
Indication
AnaemiaIndication
CancerIndication
Chemotherapy-Induced AnemiaIndication
Liver Transplant RejectionIndication
Postoperative DeliriumIndication
EncephalopathyIndication
ErythropoietinIndication
Neonatal AsphyxiaIndication
Critical IllnessIndication
Electroconvulsive TherapyIndication
Cognitive ImpairmentIndication
Major Depressive DisorderIndication
Bipolar disorderIndication
Myelodysplastic SyndromesIndication
Autoimmune Hemolytic AnemiaIndication
Immune ThrombocytopeniaIndication
CNIndication
Autoimmune NeutropeniaIndication
Cold Agglutinin DiseaseIndication
Bipolar DisorderIndication
Acute Mountain SicknessIndication
Neonatal EncephalopathyIndication
Birth AsphyxiaClinical trial
Phase III Study, Multi-center, Open, Randomized, to Assess the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood and Improvement of Quality of Life and Fatigue in Children Under Chemotherapy Treatment.Status: Not yet recruiting, Estimated PCD: 2025-05-01
Clinical trial
Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant RecipientsStatus: Active (not recruiting), Estimated PCD: 2023-05-23
Clinical trial
Erythropoietin for the Prevention of Postoperative Delirium in Elderly Patients Undergoing Total Joint Arthroplasty: Randomized Controlled StudyStatus: Completed, Estimated PCD: 2019-07-28
Clinical trial
Erythropoietin Monotherapy for Brain Regeneration in Neonatal Encephalopathy in Low and Middle-Income CountriesStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
The Practical Anemia Bundle for SusTained Blood Recovery (PABST-BR) Clinical TrialStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
Erythropoietin as an add-on Treatment for Cognitive Side-effects of Electroconvulsive TherapyStatus: Completed, Estimated PCD: 2023-01-10
Clinical trial
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic SyndromesStatus: Completed, Estimated PCD: 2008-08-01
Clinical trial
Evaluation of the Diagnostic/Therapeutic Course of Patients With Autoimmune Cytopenias (Autoimmune Hemolytic Anemia AIHA, Immune Thrombocytopenia ITP, Chronic Idiopathic/Autoimmune Neutropenia CIN/AIN) and Identification of Predictive and Prognostic Markers.Status: Recruiting, Estimated PCD: 2026-09-01
Clinical trial
Effects of Erythropoietin on Cognitive Functions and Neural Activity in Cognitively Impaired Remitted Patients With Bipolar Disorder or Recurrent Depressive Disorder and Healthy People: Study Protocol for a Randomized, Controlled TrialStatus: Completed, Estimated PCD: 2022-10-01
Clinical trial
High-dose Erythropoietin for Asphyxia and EncephalopathyStatus: Completed, Estimated PCD: 2021-10-01